TASE Announces an Historic Milestone -The Largest-Ever Equity Indices Update Kicks Off

As part of the Closing Auction on Thursday, November 6th, TASE's historically largest equity indices semi-annual update will take place. The Index Update is necessitated by the continued and substantial growth in the volume of assets managed by funds tracking TASE indices, which has reached a record high of NIS 82 billion Today, November 6, […]

NHL Superstar Nathan MacKinnon Joins Chilly Ones as Brand Ambassador

Colorado Avalanche leading scorer and Stanley Cup champion partners with Chilly Ones, the beverage company founded by former NHL veteran and Sportsnet broadcaster Tyson Barrie. Chilly Ones, the premium beer and beverage brand founded by former NHL defenseman Tyson Barrie, proudly announces that Colorado Avalanche forward Nathan MacKinnon has joined the company as its lead

Shorr Packaging Corporation earns Silver Badge from EcoVadis for Commitment to Sustainable Business Practices

Meredith Moore, Program Manager – Shorr Sustainability, said, “Shorr is honored to once again receive the Silver Badge from EcoVadis. This recognition reflects…” Shorr Packaging Corporation – an award-winning distributor of packaging products, equipment, and services- proudly announces that the company has once again earned the EcoVadis Silver Badge for its demonstrated leadership in sustainable

TNL Mediagene (NASDAQ: TNMG), as Lead Partner of TechGALA Japan 2026, Announces Keynote Speakers of TechGALA Japan 2026

TechGALA Japan 2026 confirmed Keynote Speakers and Special Session Speakers today, including: Monika Bielskyte, Nike Futurist in Residence, and expert in immersive media and information technology; Shradha Sharma, Founder & CEO, YourStory, India's leading startup media platform; Hiroshi Amano, Distinguished Professor, Nagoya University / Distinguished Professor Emeritus, Meijo University, and recipient of the 2014 Nobel

Warner Bros. Discovery Reports Third Quarter 2025 Results

Warner Bros. Discovery, Inc. (the “Company”) (Nasdaq: WBD) today reported financial results for the quarter ended September 30, 2025. Please visit the “Investor Relations” section of the Company's website at https://ir.wbd.com/to view the earnings materials. The Company will conduct a conference call today at 8:00 a.m. ET to discuss the results. A link to the

Ispire Technology Inc. Reports Financial Results for Fiscal First Quarter 2026

Cost cutting measures instituted in Fiscal 2025 helped cut total operating expenses by approximately 39% to $7.8 Million year-over-year Net Accounts Receivable Reduced approximately 29% from $62.4 Million to $44.5 Million Year-Over-Year Cash and Cash Equivalents of $22.7 Million at September 30, 2025 Ispire Technology Inc. (NASDAQ: ISPR)(“Ispire,” the “Company,” “we,” “us,” or “our”), an

GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates

(NasdaqGM:GHRS), Engagement with FDA on GH001 IND complete response ongoing Full dataset from the Phase 2b clinical trial of GH001 in TRD reported in July 2025 Long-term clinical data on safety and efficacy from Open-Label Extension presented at ECNP in October 2025 Cash, cash equivalents and marketable securities of $293.9 million as of September 30,

TransAlta Reports Third Quarter 2025 Results

(TSX:TA),(NYSE:TAC), CALGARY, Alberta, Nov. 06, 2025 (GLOBE NEWSWIRE) — TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) today reported its financial results for the third quarter ended Sept. 30, 2025. “Our business delivered solid operational performance during the third quarter, demonstrating the Company's resilience in the face of challenging market conditions. Our Alberta

TransAlta Announces President and CEO Succession

(TSX:TA),(NYSE:TAC), CALGARY, Alberta, Nov. 06, 2025 (GLOBE NEWSWIRE) — TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) announced today that John Kousinioris, President and Chief Executive Officer and a Director of TransAlta, plans to retire effective April 30, 2026. Concurrent with this announcement, the Board of Directors (Board) has appointed Joel Hunter, TransAlta's

Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

(NASDAQ:CGEM), Promising Phase 1 clinical data for CLN-049, a FLT3xCD3 bispecific T cell engager, demonstrating ~30% CRc rate in heavily pretreated, all-comer population of patients with relapsed/refractory AML to be presented in oral presentation at ASH 2025 Company to share initial data for CLN-978, a CD19xCD3 bispecific T cell engager, in both SLE and RA

Scroll to Top